Gofore Oyj
GOFORE PLC COMPANY ANNOUNCEMENT 1 MARCH 2021 AT 10.48 am EET
Acquisition of CCEA Limited completed
On 18 February 2021, Gofore Plc announced that Gofore and the sellers of CCEA Ltd. have signed an agreement whereby Gofore will acquire 95% of the share capital of CCEA Ltd., a company specialising in change execution consulting.
The purchase price of EUR 6.4 million of the share capital acquired consists of a debt-free price of EUR 6,175 million for the business and a compensation for net cash, estimated at EUR 0,255 million. The purchase price will be paid as a cash consideration of EUR 6.4 million.
The terms of the acquisition have been met today and 95% of CCEA Ltd.'s share capital has been transferred to Gofore's ownership as of 1 March 2021.
Further enquiries:
Mikael Nylund, CEO, Gofore Plc
tel. +358 40 540 2280
mikael.nylund@gofore.com
Certified Adviser: Evli Bank Plc, tel. +358 40 579 6210
Gofore Plc is a Finland-based digitalisation specialist with international growth plans. Together with our customers, we are pioneering an ethical digital world. We're made up of over 700 impact-driven people across Finland, Germany, Spain and Estonia – top experts in our industry who are our company's heart, brain, and hands. We use consulting, coding and design as tools to incite positive change. We care for our people, our customers, and the surrounding world. Our values guide our business: Gofore is a great workplace that thrives on customer success. In 2020, our revenue amounted to EUR 78 million. Gofore Plc's shares are quoted in the Nasdaq First North Growth Market Finland. Learn more: www.gofore.com.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S6.11.2025 19:00:56 CET | Press release
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
BONDUELLE6.11.2025 18:00:00 CET | Press release
BONDUELLE - Quarter 1 FY 2025-2026 Sales: The Bonduelle Group confirms its resilience in a demanding environment
Verkkokauppa.com Oyj6.11.2025 18:00:00 CET | Press release
Verkkokauppa.com Oyj: Acquisition of own shares on 6 November 2025
Vivoryon Therapeutics N.V.6.11.2025 17:31:00 CET | Press release
Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025
Aspo Plc6.11.2025 17:30:00 CET | Press release
Aspo Plc: Share repurchase 6.11.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
